Pharmacovigilance Training Course: online training
This Pharmacovigilance training module (Certificate Course) introduces learners to regulations and ICH pharmacovigilance guidelines E2 to E2F for monitoring and reporting on the safety and efficacy of pharmaceutical products.
The course content of this online training module covers drug safety monitoring and AE/SAE reporting requirements, from the earliest stages of drug development through to post-marketing drug safety surveillance responsibilities.
What you’ll learn in this newly released GMP Certificate Course for Pharmacovigilance
- Safety surveillance requirements for the safe use of pharmaceuticals (drug safety)
- Pre-marketing and post-marketing pharmaceutical product safety surveillance
- Adverse drug reactions recording and reporting requirements
- Serious adverse events (SAEs) reporting requirements in relation to pharmaceutical products, including investigational medicines (such as cannabis-derived medicines), medical devices (such as pacemakers, prosthetics, and SaMD products), and vitamin supplements in certain regions
- ICH Pharmacovigilance guidelines
- Differences between ICH guidelines and TGA guidelines for Pharmacovigilance
- Examples of Pharmacovigilance guidelines, such as:
- TGA Pharmacovigilance guidelines in Australia
- FDA Pharmacovigilance guidelines in the USA
- EMA Pharmacovigilance guidelines in Europe
- MHRA Pharmacovigilance guidelines in the UK
- Pharmacovigilance audits and compliance guidelines (what you need to know to prepare your team for compliance)
- Case studies
Who should take this Pharmacovigilance training course?
This online training option is designed for:
- anyone with an interest in drug safety monitoring and/or drug research
- professionals working in the pharmaceutical, veterinary medicines, medical devices, hospital and/or pharmacy sectors
The Pharmacovigilance online training course is suitable for both new and long-term employees, as well as contractors, researchers, pharmaceutical industry suppliers, clinical trial personnel, and life science professionals. This includes professionals involved with various components of the pharmaceutical quality systems (PQS) including quality assurance/testing, quality risk management (QRM), CAPA investigations, manufacturing procedures, packaging and labelling, pharmaceutical and medical device product marketing, ADE/SAE reporting, and complaints monitoring.
This Certificate Course makes an excellent induction course and/or regulatory compliance refresher course when combined with onsite training and appropriate Supervision.
Pharmacovigilance Certificate Course
This GMP Course includes introductions to drug safety regulations across a variety of countries.
It includes an overview of regulations and pre-marketing and post-marketing pharmaceutical safety surveillance compliance requirements from regulators such as the FDA, TGA, EMA, and MHRA; including ICH Guidelines for Pharmacovigilance and ADR/SAE reporting.
Examples of Pharmacovigilance requirements included in this course include TGA Pharmacovigilance guidelines, U.S. FDA Pharmacovigilance guidelines, and regulations for ongoing safety monitoring in various other countries (e.g., Europe, the UK, and more).
This is a well-rounded Pharmacovigilance online training course. The course is an excellent resource for individuals needing an introduction to ICH guidelines for Pharmacovigilance and efficacy reporting and/or refresher training in drug safety surveillance.
- This training module can be taken as an individual Certificate GMP course
- However, is best combined with other online GMP training modules including PIC/s Annexes 1 to 20.
- It is a useful adjunct to the herbal medicines Clinical Trials training course and/or pharmaceutical GMP training bundles specific to an industry or product.
Pharmacovigilance Training FAQs
FAQ1: Who should take this Pharmacovigilance course?
- The online training course for Pharmacovigilance compliance is suitable for a variety of professionals, contractors, suppliers, and distributors.
- This includes individuals working in public health, pharmaceutical safety, medical device. manufacturing, and pharmaceutical quality management systems (PQS/QMS), as well as professionals responsible for Quality Risk Management (QRM), regulatory audits, medical device manufacturing, and safety surveillance (including pharmacists, database managers, and other professionals with drug safety monitoring and reporting responsibilities).
FAQ2: Does this course cover Pharmacovigilance requirements for pre-marketing or postmarketing periods?
The course covers guidelines and responsibilities for pre-marketing approval Pharmacovigilance (Clinical Trials Phase I-III) as well as guidelines and regulatory requirements for post-marketing (Phase IV) Pharmacovigilance systems.
FAQ3: Which regions does this course cover?
This course provides examples of pharmacovigilance governance for several countries. It references the relevant Regulatory Authority in different regions, with examples focused on Australia (TGA), the United States (US FDA), the Europe Union (the EU EMA), and the UK (MHRA).
Learn more about complying with pre-marketing pharmacovigilance requirements and adverse event reporting responsibilities (e.g. safety signal monitoring and reporting requirement during early investigational phases of clinical trials) as well as post-approval marketing safety monitoring and reporting requirements by ordering and completing this online training course.
Snapshot of what’s covered in the Pharmacovigilance online training module
- General requirements for monitoring and reporting on the safety of pharmaceutical products
- Guidelines and responsibilities for identifying, recording and reporting adverse drug reactions (AREs), adverse events (AEs), serious adverse events (SAEs), and suspected unexpected serious adverse reactions (SUSARs).
- Authorities and regulations that oversee pharmaceutical safety monitoring and reporting requirements (regulatory agencies such as the TGA (Australia), FDA (United States), EMA (European Union), MHRA (UK).
- Introduction to Pharmacovigilance Guidelines published by the International Council of Harmonization (ICH)
Education purposes only.
Copyright 2020. All rights reserved.
Online pharmaceutical industry induction and GMP refresher courses are best used in conjunction with additional onsite pharmacovigilance training and onsite GMP compliance monitoring.
Pharmacovigilance Training Course Duration
Average online training course completion time frame
How to complete this training course in Pharmacovigilance
- Scroll up to add this purchase to your basket (top of page)
- Then complete the purchase/checkout process to gain access to this course
- Next, check your emails (including your filtered folders) for an email containing your course login details, which should arrive fairly quickly into your email INBOX (please ensure you use your correct email address)
- If you don’t see this login information email in your INBOX, search your mailbox folders for ‘onlinegmptraining’ and/or search for the words ‘course’ and/or ‘Pharmacovigilance’
- Once you locate this email, log in and begin your Pharmacovigilance training
You will have access to the course for 12 months from the date of purchase; e.g. one user per licence and one Certificate of Completion per completed training course.
- You’ll gain access immediately upon completing your online purchase of the module.
- You can complete this course in multiple sittings or complete the training all at once.
For education purposes only. Single user licence only.
The Certificate of Completion is not a statement of competence but affirms you completed the online Pharmacovigilance course.
You can download, print and/or email your Certificate of Completion after successfully completing the Final Assessment of this online training course.
- This training is for education purposes only and is designed to supplement your specific onsite training, induction training and direct Supervision for pharmacovigilance and other drug safety regulation compliance in your workplace.
- Once you complete this course, please continue to refer to the current regulations that apply to your specific region and specific product type(s)/marketing authorisations.